Nutrient therapy in early period after living donor liver transplantation

Nutrient therapy in early period after living donor liver transplantation - Nutrient therapy after liver living donor transplantation

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000004323

Enrollment

Registered

2010-10-04

Start date

2010-10-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patient with end-stage liver cirrhosis who undergo living donor liver transplantation

Interventions

Oral supplementation with two pack of Aminoreban EN Not oral supplementation of Aminoreban EN

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with end-stage liver disease who undergo living donor liver transplantation

Exclusion criteria

Exclusion criteria: 1) History of anaphylactic reaction for amino acid nutrient 2) Congenital amino-acid metabolism abnormality 3) Milk allergy

Design outcomes

Primary

Measure	Time frame
Respiratory Quotient Liver Function	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026